These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 18392092)

  • 21. Hepatitis C virus escape from the interferon regulatory factor 3 pathway by a passive and active evasion strategy.
    Binder M; Kochs G; Bartenschlager R; Lohmann V
    Hepatology; 2007 Nov; 46(5):1365-74. PubMed ID: 17668876
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of the hepatitis C virus core protein on innate cellular defense pathways.
    Miller K; McArdle S; Gale MJ; Geller DA; Tenoever B; Hiscott J; Gretch DR; Polyak SJ
    J Interferon Cytokine Res; 2004 Jul; 24(7):391-402. PubMed ID: 15296650
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of the nonstructural protein 4B of hepatitis C virus as a factor that inhibits the antiviral activity of interferon-alpha.
    Xu J; Liu S; Xu Y; Tien P; Gao G
    Virus Res; 2009 Apr; 141(1):55-62. PubMed ID: 19185598
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Porcine epidemic diarrhea virus inhibits dsRNA-induced interferon-β production in porcine intestinal epithelial cells by blockade of the RIG-I-mediated pathway.
    Cao L; Ge X; Gao Y; Herrler G; Ren Y; Ren X; Li G
    Virol J; 2015 Aug; 12():127. PubMed ID: 26283628
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficient virus assembly, but not infectivity, determines the magnitude of hepatitis C virus-induced interferon alpha responses of plasmacytoid dendritic cells.
    Grabski E; Wappler I; Pfaender S; Steinmann E; Haid S; Dzionek A; Pietschmann T; Kalinke U
    J Virol; 2015 Mar; 89(6):3200-8. PubMed ID: 25552725
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Activation of intracellular signaling by hepatitis B and C viruses: C-viral core is the most potent signal inducer.
    Kato N; Yoshida H; Ono-Nita SK; Kato J; Goto T; Otsuka M; Lan K; Matsushima K; Shiratori Y; Omata M
    Hepatology; 2000 Aug; 32(2):405-12. PubMed ID: 10915750
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of short RNA structural analogues against hepatitis C virus genotypes 2, 3 and 4 in replicon cells.
    Elshaffei IM; Gupta N; Wu CH; Wu DC; Hammad LN; Abo-Elmatty DM; Mesbah NM; Wu GY
    J Dig Dis; 2015 Aug; 16(8):449-55. PubMed ID: 25873200
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Introduction of replication-competent hepatitis C virus transcripts using a tetracycline-regulable baculovirus delivery system.
    McCormick CJ; Challinor L; Macdonald A; Rowlands DJ; Harris M
    J Gen Virol; 2004 Feb; 85(Pt 2):429-439. PubMed ID: 14769901
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hairpin ribozymes in combination with siRNAs against highly conserved hepatitis C virus sequence inhibit RNA replication and protein translation from hepatitis C virus subgenomic replicons.
    Jarczak D; Korf M; Beger C; Manns MP; Krüger M
    FEBS J; 2005 Nov; 272(22):5910-22. PubMed ID: 16279954
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficient replication of a full-length hepatitis C virus genome, strain O, in cell culture, and development of a luciferase reporter system.
    Ikeda M; Abe K; Dansako H; Nakamura T; Naka K; Kato N
    Biochem Biophys Res Commun; 2005 Apr; 329(4):1350-9. PubMed ID: 15766575
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hepatitis C virus replication is inhibited by 22beta-methoxyolean-12-ene-3beta, 24(4beta)-diol (ME3738) through enhancing interferon-beta.
    Hiasa Y; Kuzuhara H; Tokumoto Y; Konishi I; Yamashita N; Matsuura B; Michitaka K; Chung RT; Onji M
    Hepatology; 2008 Jul; 48(1):59-69. PubMed ID: 18459156
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interaction between the HCV NS3 protein and the host TBK1 protein leads to inhibition of cellular antiviral responses.
    Otsuka M; Kato N; Moriyama M; Taniguchi H; Wang Y; Dharel N; Kawabe T; Omata M
    Hepatology; 2005 May; 41(5):1004-12. PubMed ID: 15841462
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hepatitis C virus non-structural proteins responsible for suppression of the RIG-I/Cardif-induced interferon response.
    Tasaka M; Sakamoto N; Itakura Y; Nakagawa M; Itsui Y; Sekine-Osajima Y; Nishimura-Sakurai Y; Chen CH; Yoneyama M; Fujita T; Wakita T; Maekawa S; Enomoto N; Watanabe M
    J Gen Virol; 2007 Dec; 88(Pt 12):3323-3333. PubMed ID: 18024902
    [TBL] [Abstract][Full Text] [Related]  

  • 34. TRIM27 Promotes Hepatitis C Virus Replication by Suppressing Type I Interferon Response.
    Zheng F; Xu N; Zhang Y
    Inflammation; 2019 Aug; 42(4):1317-1325. PubMed ID: 30847745
    [TBL] [Abstract][Full Text] [Related]  

  • 35. HCV modifies EGF signalling and upregulates production of CXCR2 ligands: Role in inflammation and antiviral immune response.
    Groepper C; Rufinatscha K; Schröder N; Stindt S; Ehlting C; Albrecht U; Bock HH; Bartenschlager R; Häussinger D; Bode JG
    J Hepatol; 2018 Sep; 69(3):594-602. PubMed ID: 29705238
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Repression of interferon regulatory factor 1 by hepatitis C virus core protein results in inhibition of antiviral and immunomodulatory genes.
    Ciccaglione AR; Stellacci E; Marcantonio C; Muto V; Equestre M; Marsili G; Rapicetta M; Battistini A
    J Virol; 2007 Jan; 81(1):202-14. PubMed ID: 17050603
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interferon resistance of hepatitis C virus replicon-harbouring cells is caused by functional disruption of type I interferon receptors.
    Naka K; Takemoto K; Abe KI; Dansako H; Ikeda M; Shimotohno K; Kato N
    J Gen Virol; 2005 Oct; 86(Pt 10):2787-2792. PubMed ID: 16186233
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of a full-length hepatitis C virus cDNA up-regulates the expression of CC chemokines MCP-1 and RANTES.
    Soo HM; Garzino-Demo A; Hong W; Tan YH; Tan YJ; Goh P; Lim SG; Lim SP
    Virology; 2002 Nov; 303(2):253-77. PubMed ID: 12490388
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intrahepatic angiopoietin-2 correlates with chronic hepatitis C progression and is induced in hepatitis C virus replicon systems.
    Hernández-Bartolomé Á; López-Rodríguez R; García-Buey L; Martín-Vílchez S; Rodríguez-Muñoz Y; Borque MJ; González-Moreno L; Real-Martínez Y; Mendoza-Ridruejo J; Martín-Pérez E; Moreno-Otero R; Sanz-Cameno P
    Liver Int; 2017 Aug; 37(8):1148-1156. PubMed ID: 28027429
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficient delivery and regulable expression of hepatitis C virus full-length and minigenome constructs in hepatocyte-derived cell lines using baculovirus vectors.
    McCormick CJ; Rowlands DJ; Harris M
    J Gen Virol; 2002 Feb; 83(Pt 2):383-394. PubMed ID: 11807231
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.